Papa is on a mission to make a difference in health care. His company makes store-brand, over-the-counter remedies and generic versions of prescription drugs. And it’s staked its future on trying to make it’s products affordable for everyone.
Papa has proven a pharmaceutical company doesn’t have to gouge to make money. Since becoming CEO of Perrigo in November 2006, the company’s revenues have nearly tripled, from $1.4 billion that year to $3.9 billion in 2013, and and its stock has risen a 700%.
This is a refreshing change in a world where health care costs rise many times more the rate of inflation each year.
Click here to read my profile of Papa at Investors Business Daily.
ALSO READ: My interview with Charles Schwab.